We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Form 483 Reveals Quality Issues At Troubled Ranbaxy Plant
Form 483 Reveals Quality Issues At Troubled Ranbaxy Plant
A Form 483 describes the quality problems that led the FDA to ban imports from Ranbaxy’s Toansa, India plant, with investigators troubled by workers retesting samples until they get acceptable results.